Physician profile
Sequioa R Ducasse
NPI 1194184879
$8,451.54
in general payments reported to CMS, 2019-2025
18 companies · $2,435 in 2025
The $2,435 reported for 2025 was more than what 86% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.36 · 2020: $216 · 2021: $312 · 2022: $86.65 · 2023: $1,846 · 2024: $3,518 · 2025: $2,435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,207 · Consulting Fee: $2,600 · Food and Beverage: $1,991.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,207.49 |
| Consulting Fee | $2,600.00 |
| Food and Beverage | $1,990.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,207.05 | 2023-2025 | Grafix, Versajet, Pico |
| Integra Lifesciences Corporation | $2,836.92 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| United Orthopedics LLC | $557.68 | 2024 | |
| Bioness INC | $528.39 | 2020-2021 | |
| Arthrex, INC. | $474.90 | 2024 | |
| Bioventus LLC | $265.06 | 2022-2023 | Stimrouter Implantable Kit |
| Biotronik Nro, INC. | $186.22 | 2024 | Prospera |
| Kerecis Limited | $88.21 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Averitas Pharma INC. | $78.41 | 2024 | Qutenza |
| Orthofix Medical, INC. | $51.19 | 2023 | Truelok |
| Ibsa Pharma INC. | $35.68 | 2023 | Tirosint, Licart |
| Vertex Pharmaceuticals Incorporated | $30.47 | 2025 | |
| Trice Medical, INC. | $28.22 | 2024 | |
| Osiris Therapeutics INC. | $20.41 | 2019 | |
| Nevro Corp. | $20.39 | 2023 | Senza |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axogen | $17.95 | 2019 | |
| Stryker Corporation | $14.71 | 2024 | Salvation |
| Spr Therapeutics, INC | $9.68 | 2025 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sequioa Ducasse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.